Oral tablets containing prasugrel hydrochloride, provided by pharmaceutical suppliers to specialized distributors and acute care facilities. Sourced by interventional cardiology departments for dual antiplatelet therapy in patients undergoing percutaneous coronary intervention with stent placement.